| 000 | 01473 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513085236.0 | ||
| 264 | 0 | _c19960320 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0042-9007 | ||
| 024 | 7 |
_a10.1111/j.1423-0410.1995.tb01675.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEbeling, F | |
| 245 | 0 | 0 |
_aTolerability and kinetics of a solvent-detergent-treated intravenous immunoglobulin preparation in hypogammaglobulinaemia patients. _h[electronic resource] |
| 260 |
_bVox sanguinis _c1995 |
||
| 300 |
_a91-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAgammaglobulinemia _xtherapy |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDetergents |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadverse effects |
| 650 | 0 | 4 |
_aInfusions, Intravenous _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSolvents |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBaer, M | |
| 700 | 1 | _aHormila, P | |
| 700 | 1 | _aJärventie, G | |
| 700 | 1 | _aKoistinen, P | |
| 700 | 1 | _aKätkä, K | |
| 700 | 1 | _aOksanen, K | |
| 700 | 1 | _aPerkkiö, M | |
| 700 | 1 | _aRuutu, T | |
| 700 | 1 | _aSoppi, E | |
| 773 | 0 |
_tVox sanguinis _gvol. 69 _gno. 2 _gp. 91-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1423-0410.1995.tb01675.x _zAvailable from publisher's website |
| 999 |
_c8584258 _d8584258 |
||